Related references
Note: Only part of the references are listed.25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis
Pilar Peris et al.
BONE (2012)
Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials
S-L. Han et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency Revisited
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The 25(OH)D level needed to maintain a favorable bisphosphonate response is aparts per thousandyen33 ng/ml
A. S. Carmel et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Bisphosphonates for postmenopausal osteoporosis
Richard Eastell et al.
BONE (2011)
Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency
Stuart H. Ralston et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review
Mary Barna Bridgeman et al.
CLINICAL THERAPEUTICS (2011)
Long-term raloxifene for postmenopausal osteoporosis
Robert R. Recker et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
IOF position statement: vitamin D recommendations for older adults
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women
Muneaki Ishijima et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Vitamin D insufficiency does not affect response of bone mineral density to alendronate
D. M. Antoniucci et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Vitamin D status and response to treatment in post-menopausal osteoporosis
S. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Secondary hyperparathyroidism due to hypovitaminosis d affects bone mineral density response to alendronate in elderly women with osteoporosis: A randomized controlled trial
Antonella Barone et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study
Silvano Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Determinants of adherence to osteoporosis treatment in clinical practice
M. Rossini et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy
MF Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)